Introduction: In order to better control renal pelvic pressure (RPP), reduce surgical complications and increase operative efficacy of minimally invasive percutaneous nephrolithotomy (MPCNL), we designed an MPCNL with intelligent monitoring and control of RPP and sought to explore its clinical efficacy and characteristics. Subject and Methods: This study included 60 patients with renal staghorn calculi. A 5F ureteral catheter was connected to an invasive blood pressure monitor for monitoring and control of RPP. A 12F renoscope was inserted through a percutaneous tract for lithotripsy using a laser, with the help of an intelligent system to monitor RPP continuously, which includes an irrigation and suctioning platform and an integrated intraluminal pressure sensory PCNL suctioning sheath. Before the lithotripsy, intraluminal pressure control value and perfusion flow were set on the platform. Results: RPP was maintained at a range of -12 to 2 mm Hg. The mean operative time was 120 min. The mean intraoperative bleeding amount was 100 ml. Fifty-two of the 60 patients the stones were cleared by one surgery. Conclusions: In our suctioning MPCNL with the intelligent control of RPP, the intraoperative RPP could be accurately controlled within the preset safety range. The stone clearance rate was high.

Keywords:
Renal pelvic pressure, Intelligent control, Pressure feedback, Suctioning minimally invasive percutaneous nephrolithotomy, Renal staghorn calculus
1.
Li LY, Gao X, Yang M, Li JF, Zhang HB, Xu WF, Lin Z: Does a smaller tract in percutaneous nephrolithotomy contribute to less invasiveness? A prospective comparative study. Urology 2010;75:56-61.
2.
Eswara JR, SharifTabrizi A, Sacco D: Positive stone culture is associated with a higher rate of sepsis after endourological procedures. Urolithiasis 2013;41:411-414.
3.
Ghani KR, Sammon JD, Bhojani N, Karakiewicz PI, Sun M, Sukumar S, Littleton R, Peabody JO, Menon M, Trinh QD: Trends in percutaneous nephrolithotomy use and outcomes in the United States. J Urol 2013;190:558-564.
4.
Michel MS, Trojan L, Rassweiler JJ: Complications in percutaneous nephrolithotomy. Eur Urol 2007;51:899-906.
5.
Kreydin EI, Eisner BH: Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol 2013;10:598-605.
6.
Zhong W, Zeng G, Wu K, Li X, Chen W, Yang H: Does a smaller tract in percutaneous nephrolithotomy contribute to high renal pelvic pressure and postoperative fever? J Endourol 2008;22:2147-2151.
7.
Na Y, Ye Z, Sun Y, Sun G: The Chinese Urological Disease Diagnosis Treatment Guide. Beijing, People's Medical Publishing House, 2014, p 129.
8.
Wein A: Campbell-Walsh UROLOGY. Peking University Press, 2009, p 1441.
9.
Yuhico MP, KO R: The current status of percutaneous nephrolithotomy in the management of kidney stones. Minerva Urol Nefrol 2008;60:159-175.
10.
Wang F, An HQ, Li J, Tian CY, Wang YJ: Minimally invasive percutaneous nephrolithotomy in children less than three years of age: five-year experience in 234 cases. Urol Int 2014;92:433-439.
11.
Karatag T, Buldu I, Inan R, Istanbulluoglu MO: Is micropercutaneous nephrolithotomy technique really efficacicous for the treatment of moderate size renal calculi? yes. Urol Int 2015;95:9-14.
12.
Ozden E, Mercimek MN, Bostanci Y, Yakupoglu YK, Sirtbas A, Sarikaya S: Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology 2012;79:990-994.
13.
Ye LH, Chen YL, Xu DS, et al: Clinical comparative study of five minimally invasive surgeries for upper urinary tract calculi. Zhonghua Yi Xue Za Zhi 2010;90:228-230.
14.
Kontak JA, Wright AD, Turk TM, et al: Treatment of symptomatic caliceal diverticula using a mini-percutaneous technique with greater than 3-year follow-up. J Endourol 2007;21:862-865.
15.
Song L, Chen Z, Liu T, Zhong J, Qin W, Guo S, Peng Z, Hu M, Du C, Zhu L, Yao L, Yang Z, Huang J, Xie D: The application of a patented system to minimally invasive percutaneous nephrolithotomy. J Endourol 2011;25:1281-1286.
16.
Yang Z, Song L, Xie D, Hu M, Peng Z, Liu T, Du C, Zhong J, Qing W, Guo S, Zhu L, Yao L, Huang J, Fan D, Ye Z: Comparative study of outcome in treating upper ureteral impacted stones using minimally invasive percutaneous nephrolithotomy with aid of patented system or transurethral ureteroscopy. Urology 2012;80:1192-1197.
17.
Ye Z, Yu X: Stone treatment in the era of minimally invasive surgery. Chin J Urol 2013;34:249.
18.
Song L, Fan D, Du C, Liu T, Yang Z, Zhong J, Peng G, Hu M, Yao L, Peng Z, Zhu L: The value of suctioning stone clearance system combined with ultrasonic lithotripsy in minimally invasive nephrolithotomy for the treatment of staghorn calculi. Chin J Urol 2013;34:254-257.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.